Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 09, 2023

SELL
$6.09 - $7.93 $138,029 - $179,733
-22,665 Reduced 20.94%
85,580 $537,000
Q3 2022

Nov 10, 2022

BUY
$4.58 - $9.21 $214,847 - $432,041
46,910 Added 76.48%
108,245 $746,000
Q2 2022

Jul 26, 2022

BUY
$7.06 - $23.63 $188,636 - $631,369
26,719 Added 77.19%
61,335 $513,000
Q1 2022

May 10, 2022

SELL
$21.6 - $27.79 $117,201 - $150,788
-5,426 Reduced 13.55%
34,616 $791,000
Q4 2021

Feb 08, 2022

BUY
$23.0 - $29.01 $38,272 - $48,272
1,664 Added 4.34%
40,042 $1.11 Million
Q3 2021

Nov 15, 2021

BUY
$25.04 - $30.06 $132,712 - $159,318
5,300 Added 16.02%
38,378 $1.07 Million
Q2 2021

Aug 11, 2021

SELL
$27.43 - $32.7 $33,108 - $39,468
-1,207 Reduced 3.52%
33,078 $970,000
Q1 2021

May 13, 2021

SELL
$21.37 - $34.38 $525,125 - $844,819
-24,573 Reduced 41.75%
34,285 $1.09 Million
Q4 2020

Feb 10, 2021

SELL
$15.31 - $21.12 $1,331 - $1,837
-87 Reduced 0.15%
58,858 $1.22 Million
Q3 2020

Nov 12, 2020

BUY
$14.88 - $20.13 $342 - $462
23 Added 0.04%
58,945 $916,000
Q2 2020

Aug 11, 2020

BUY
$13.31 - $20.51 $258,573 - $398,447
19,427 Added 49.19%
58,922 $1.08 Million
Q1 2020

May 12, 2020

BUY
$12.98 - $30.25 $54,204 - $126,324
4,176 Added 11.82%
39,495 $612,000
Q4 2019

Feb 12, 2020

SELL
$18.89 - $31.89 $191,903 - $323,970
-10,159 Reduced 22.34%
35,319 $1.06 Million
Q3 2019

Nov 12, 2019

BUY
$20.88 - $25.66 $145,533 - $178,850
6,970 Added 18.1%
45,478 $994,000
Q2 2019

Aug 13, 2019

BUY
$20.52 - $26.45 $790,184 - $1.02 Million
38,508 New
38,508 $971,000

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.